Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
11/2003
11/27/2003WO2003097618A1 Morpholinylmethylureas ccr-3 receptor antagonists
11/27/2003WO2003024899A3 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
11/18/2003US6649758 Heating, pressurization
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003US20030212116 Contorlling plant disease
11/13/2003US20030212049 Antiarthritic agents; osteoporosis; sepsis; antiulcer agents; Crohn's disease
11/12/2003EP1360180A1 Phenothiazine kinesin inhibitors
11/11/2003US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2003090782A1 Cell death inhibitor
11/06/2003US20030207934 Such as ((S)-1-benzyl-2-oxo-but-3-enyl)-carbamic acid tert-butyl ester; for treating human immunodeficiency virus; antimalarial agents
11/06/2003US20030207880 Heterocycle carboxamides as antiviral agents
11/06/2003US20030207869 Method for controlling pests, characterized in that at least one compound of the formula (I) according to claim 1 or a pesticide according to claim 7 is allowed to act on pests and/ or their habitat.
11/06/2003US20030207248 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET)
11/05/2003EP0814847B1 Methods and compositions for in-vivo detection of oral cancers and precancerous conditions
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
10/2003
10/29/2003EP1089964B1 Hydrazine derivatives
10/28/2003US6639033 N-oxyl radicals
10/28/2003US6638930 Morpholine and thiomorpholine tachykinin receptor antagonists
10/23/2003US20030199572 Use as pesticides and herbicides
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003US20030192138 Novel benzothiazine dyes for imaging elements
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351946A2 Materials and methods to potentiate cancer treatment
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/02/2003US20030187256 Benoxazinones/benzothiazinones as serine protease inhibitors
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186971 Using 1,3-benothiazine compound
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
09/2003
09/30/2003US6627627 Aralkyl and aralkylidene heterocyclic lactams and imides
09/25/2003US20030181444 Heterocyclic amines such as 4-(3,4-dichlorophenyl)-2-(2-(4-methylpiperazin-1-yl)-benzylidene) -thiomorpholin-3-one, used as antiserotonine agents
09/25/2003US20030181441 Tumor necrosis factor-alpha converting enzyme antagonists, such as (2S,3S)-4-(4-(3,5-difluro-benzyloxy)-benzenesulfonyl) -2-methyl-thiomorpholine-3-carboxylic acid hydroxyamide, used as antiarthritic or anticarcinogenic agents
09/24/2003EP1345917A1 2-(2-(4-((2r)-2-methyl-3-(10h-phenothiazin-10-yl)propyl)-1-piperazinyl)-ethoxy)ethanol, process for the preparation thereof, pharmaceutical compositions containing said compound and therapeutic uses thereof
09/24/2003CN1444564A Biphenyl carboxamides
09/17/2003EP1343774A1 1,1-dioxo-2h-1, 2-benzothiazine-3-carboxamide derivatives, method for preparing same and pharmaceutical compositions comprising same
09/16/2003US6620809 Substituted (dihydro)benzoxazine and (dihydro)benzothiazine compounds
09/16/2003CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures
09/11/2003US20030171367 Nitrogen-containing tricyclic compounds and drugs containing the same
09/11/2003US20030171219 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
09/04/2003WO2003072567A1 Novel fused ring compounds, and their use as cationic photoinitiators
09/03/2003EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands
09/02/2003US6613783 Non-systemic control of parasites
08/2003
08/28/2003WO2003070277A1 Antipruritics
08/27/2003CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
08/21/2003WO2002020463A3 Fxr modulators
08/21/2003US20030158204 Diamino phenothiazine derivatives and composition comprising same
08/21/2003US20030158186 Compositions and methods for treating heart failure
08/20/2003EP0776330B1 Photolabile compounds and methods for their use
08/19/2003US6608195 Process for the preparation of 2-(4-alkyl-1-piperazinyl)-benzaldehyde and -benzylidenyl compounds
08/19/2003US6608194 Hypolipidemic, antihyperglycemic, antiobesity and hypocholes-terolemic agents
08/19/2003CA2043733C Aromatic compounds
08/14/2003WO2003066612A1 Novel polymorphic forms of bicyclic antidiabetic agents: process for their preparation and pharmaceutical compositions containing them
08/14/2003US20030153763 Indolinyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydro isoquinolinyl, benz(cd)indolinyl and 5,6-dihydrophen anthridinyl compounds; treating neurodegenerative disorders
08/13/2003EP1334999A2 Polymethine and azomethine dyes for imaging elements
08/13/2003CN1436180A Diamino phenothiazine derivs. and composition comprising same
08/06/2003EP0686632B1 Benzothiazine derivative
07/2003
07/31/2003WO2003062388A2 Inhibition of rna function
07/31/2003WO2003062213A1 Nile red type compound emitting red light, process for producing the same, and luminescent element utilizing the same
07/31/2003WO2002020500A3 Materials and methods to potentiate cancer treatment
07/31/2003US20030144504 Dialkyl-halogenophenyl-substituted ketoenols
07/31/2003US20030144274 Preferential enzyme inhibitors such as 3-(4-Methoxyphenyl)-prop-1-ynyl)-N-(4-carboxybenzyl)benzamide, used for prophylaxis of degenerative diseases including cancer and arthritis
07/30/2003CN1433411A Chemical compounds
07/30/2003CN1433409A Phenothiazines in prill form
07/29/2003US6600035 6-(substituted methylene) penems and intermediates
07/29/2003US6599890 Inhibitors of matrix metalloproteinases or the production of tumor necrosis factor
07/24/2003WO2003059265A2 Compositions and methods for treating heart failure
07/24/2003US20030139388 Antiinflammatory agents; osteoporosis
07/23/2003EP0929528B1 Aralkyl and aralkylidene heterocyclic lactams and imides
07/22/2003US6596716 2-propane-sulphonamide derivatives
07/16/2003CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/15/2003US6593013 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye
07/10/2003WO2003055851A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
07/10/2003WO2002096368A3 Encapsulation of nanosuspensions in liposomes and microspheres
07/10/2003US20030130506 4-phenoxy or 4-(pyrid-4-yloxy)- benzensulfonic acid derivatives; antitumor and antiarthritic agents
07/10/2003US20030130271 1,3-Diheterocyclic metalloprotease inhibitors
07/10/2003US20030130238 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/09/2003EP1325918A1 Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases
07/09/2003CN1113603C Azine derivatives
07/03/2003WO2003053979A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003WO2003053978A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003WO2003053947A1 Benzothia(dia)zine derivatives and their use as ampa modulators
07/03/2003CA2471263A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003CA2471120A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003CA2471057A1 Benzothia(dia)zine derivatives and their use as ampa modulators
07/02/2003EP1322627A1 Cyclic sulfonyl compounds as inhibitors of metalloproteases
06/2003
06/25/2003CN1425656A 1-(alpha-aminobenzyl)-2 naphthol ketal (acetal) compound and its preparation and use
06/24/2003US6583281 Using phenothiazine
06/24/2003US6583144 Piperazine substituted isoquinoline, 1,3-benzoxazine, or 1,3-benzothiazine derivatives; inhibitors against the biosynthesis of triglycerides and secretion of apolipoprotein b and treatment of hyperlipidemia
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/12/2003WO2003048141A1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/12/2003US20030109521 Aryl substituted thiazolidinones and the use thereof
06/11/2003EP1024810A4 Method for optimizing retinal and optic nerve health
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/04/2003EP0783507B1 Compounds useful as antiproliferative agents and garft inhibitors
06/04/2003CN1422253A Carbamate caspase inhibitors and uses thereof
06/03/2003US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability
06/03/2003CA2053954C Process for the preparation of nitroguanidine derivatives
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 52